AKT1 and diabetes mellitus: These pathways are well known to participate in ECM metabolism, angiogenesis, and inflammatory regulation, indicating that COL6A2 may contribute to structural remodeling and functional impairment of the diabetic retina by modulating the ECM-integrin axis and downstream AKT activation.